Filing search / Legend Biotech Corporation / "Materials"

6-K

EX-99.1

LEGN Legend Biotech Corporation

20 Sep 24

Current report (foreign)

8:01am

of solicitation materials will be furnished to all holders of Ordinary Shares of the Company, including banks, brokerage houses, fiduciaries and custodians

6-K

LEGN Legend Biotech Corporation

20 Sep 24

Current report (foreign)

8:01am

Cottontail Lane, Somerset, NJ 08873, USA. Materials made available in connection with the Meeting are available on the Company’s website

6-K

LEGN Legend Biotech Corporation

9 Aug 24

Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights

7:01am

materials from Legend Biotech’s Report on Form 6-K for the six months ended June 30, 2024 formatted in XBRL (eXtensible Business Reporting Language … Revenue Other revenue primarily includes supply of materials by us to Novartis under the terms of the Novartis License Agreement. The following table

6-K

LEGN Legend Biotech Corporation

13 May 24

Legend Biotech Reports First Quarter 2024 Results and Recent Highlights

7:01am

The following materials from Legend Biotech’s Report on Form 6-K for the three months ended March 31, 2024 formatted in XBRL (eXtensible Business … 31,2023 US$’000(Unaudited) US$’000 Raw materials Work-in-process Finished goods Total collaboration inventories The Company's reserve for inventory

6-K

LEGN Legend Biotech Corporation

29 Mar 24

Current report (foreign)

8:00am

of certain raw materials used in manufacturing the Product. The Agreement also includes customary representations and warranties and covenants relating

F-3ASR

yj2uzs9k2vdcs

19 Mar 24

Automatic shelf registration (foreign)

7:57am

F-3ASR

EX-4.4

q4yjjup6t

19 Mar 24

Automatic shelf registration (foreign)

7:57am

6-K

3qtki xcoknlhsrd

13 Mar 24

Current report (foreign)

8:36am

6-K

EX-99.1

i2lloalc3d8wg681qc

9 Jan 24

Legend Biotech Corporation 6-K

4:01pm

6-K

jnre7be0d

20 Nov 23

Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights

6:02am

CORRESP

sp2h1

8 Sep 23

Correspondence with SEC

12:00am

UPLOAD

cccvws8 qwz8qeugj

31 Aug 23

Letter from SEC

12:00am

6-K

bj85ljvqjj88hy41 so

28 Aug 23

Legend Biotech Corporation 6-K

10:00am

6-K

187d8

21 Aug 23

Current report (foreign)

4:14pm

6-K

EX-99.1

frlk73

21 Aug 23

Current report (foreign)

4:14pm

6-K

2o2z9eiltu9ck447t3eo

15 Aug 23

Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights

6:10am